Figure 4 | Oncogene

Figure 4

From: Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis

Figure 4

SFRP1 methylation analyses of primary breast cancer specimens. Methylation-specific PCR (MSP) was performed on bisulphite-treated DNA from breast cancer (T) and matching normal primary breast tissue (N). MSP results from seven representative patients are shown. DNA bands in lanes labelled with U indicate PCR products amplified with primers recognising the unmethylated promoter sequence. DNA bands in lanes labelled with M represent amplified products with methylation-specific primers. Human placenta (PL) and in vitro methylated DNA (IVD) served as positive controls for the U and M reaction, respectively. Water was used as template in the negative control (NTC). Note that tumour tissue usually displayed a PCR product in the U-reaction as well, due to contaminating normal tissue (stromal cells, endothelial cells) present in the tumour specimens as has also been described by Suzuki et al. (2004).

Back to article page